Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

STO/BIOG.B stock hub

STO/BIOG.B has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

STO/BIOG.Bis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

13B

Nasdaq Stockholm

Market data

Live price

Current market quote for this ticker.

Current price

STO/BIOG.B

In the news

Latest news · STO/BIOG.B

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E29.4

P25 14.9P50 22.5P75 31.5

Trailing P/E39.2

P25 17.3P50 29.9P75 44.5

ROE21.9

P25 -86.1P50 -28.3P75 4.6

ROIC68.1

P25 -52.4P50 -16.9P75 5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All STO/BIOG.B market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

246

Groups with data

Currency

SEK

Showing 246 of 246 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Sweden
Country code	SE
Employees	242
Employees Change	17%
Employees Change Percent	7.56
Enterprise value	SEK 12.3B
Exchange	Nasdaq Stockholm
Financial currency	SEK
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	SE0017769995
Last refreshed	2026-05-10
Market cap	SEK 13B
Price	SEK 129
Price currency	SEK
Rev Per Employee	6,356,066.12x
Sector	Healthcare
Sic	2834
Symbol	sto/BIOG.B
Website	https://www.biogaiagroup.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	2.55%
EV Earnings	36.82x
EV/EBIT	27.11x
EV/EBITDA	25.7x
EV/FCF	40.43x
EV/Sales	7.97x
FCF yield	2.33%
Forward P/E	29.39x
P/B ratio	9.91x
P/E ratio	39.16x
P/S ratio	8.47x
PE Ratio10 Y	35.46x
PE Ratio3 Y	31.07x
PE Ratio5 Y	35.93x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	29.38%
EBITDA Margin	30.49%
FCF margin	19.7%
Gross margin	73.37%
Gross Profit	SEK 1.1B
Gross Profit Growth	9.49%
Gross Profit Growth Q	25.25%
Gross Profit Growth3 Y	12.06%
Gross Profit Growth5 Y	15.59%
Net Income	SEK 332.8M
Net Income Growth	-5.3%
Net Income Growth Q	20.56%
Net Income Growth Years	0%
Net Income Growth3 Y	-3.8%
Net Income Growth5 Y	13.11%
Pretax Margin	27.38%
Profit Margin	21.63%
Profit Per Employee	SEK 1.4M
Profitable Years	20
ROA	15.56
Roa5y	11.62
ROCE	32.31
ROE	21.91
Roe5y	17.83
ROIC	68.07
Roic5y	63.89

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	15.39%
Cagr15y	15.68%
Cagr1y	34.24%
Cagr20y	20.35%
Cagr3y	12.7%
Cagr5y	13.4%
Div CAGR10	14.87%
Div CAGR3	11.32%
Div CAGR5	42.45%
EPS Growth	-5.38
EPS Growth Q	21.2
EPS Growth Years	0
EPS Growth3 Y	-3.84
EPS Growth5 Y	10.32
FCF Growth	-15.7%
FCF Growth Q	-18.96%
FCF Growth3 Y	0.22%
FCF Growth5 Y	8.11%
OCF Growth	-17.86%
OCF Growth Q	-18.23%
OCF Growth10 Y	10.06%
OCF Growth3 Y	-1.31%
OCF Growth5 Y	6.74%
Revenue Growth	8.12x
Revenue Growth Q	20.76x
Revenue Growth Quarters	4x
Revenue Growth Years	5x
Revenue Growth3 Y	11.69x
Revenue Growth5 Y	15.54x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	SEK 0.85
Assets	SEK 1.6B
Cash	SEK 801.3M
Current Assets	SEK 1.2B
Current Liabilities	SEK 199.1M
Debt	SEK 23.2M
Debt EBITDA	SEK 0.05
Debt Equity	SEK 0.02
Debt FCF	SEK 0.08
Equity	SEK 1.3B
Interest Coverage	74.62
Liabilities	SEK 283.6M
Long Term Assets	SEK 378.7M
Long Term Liabilities	SEK 84.4M
Net Cash	SEK 778.1M
Net Cash By Market Cap	SEK 5.97
Net Cash Growth	-34.86%
Net Debt EBITDA	SEK -1.66
Net Debt Equity	SEK -0.59
Net Debt FCF	SEK -2.57
Tangible Book Value	SEK 1.2B
Tangible Book Value Per Share	SEK 11.54
WACC	5.96

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	6.12
Inventory Turnover	2.56
Net Working Capital	SEK 225.5M
Quick ratio	5.21
Working Capital	SEK 1B
Working Capital Turnover	SEK 1.27

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.09%
Dividend Growth	-42.03%
Dividend Growth Years	0%
Dividend per share	SEK 4
Dividend Years	18
Dividend Yield	3.11%
Ex Div Date	2026-05-08
Last Dividend	SEK 4
Payout Frequency	Annual
Payout Ratio	59.28%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	318.4%
1Y total return	34.21%
200-day SMA	106.7
3Y total return	43.16%
50-day SMA	116.3
50-day SMA vs 200-day SMA	50over200
5Y total return	87.54%
All Time High	139.7
All Time High Change	-7.8%
All Time High Date	2025-02-04
All Time Low	0.84
All Time Low Change	15,233.33%
All Time Low Date	2002-10-10
ATR	3.63
Beta	0.31
Beta1y	0.44
Beta2y	0.42
Ch YTD	21.28
High	130.3
High52	130.6
High52 Date	2026-05-07
High52ch	-1.38%
Low	124
Low52	93.2
Low52 Date	2025-08-12
Low52ch	38.2%
Ma50ch	10.74%
Price vs 200-day SMA	20.71%
RSI	68.16
RSI Monthly	62.22
RSI Weekly	68.75
Sharpe ratio	1.04x
Sortino ratio	1.87
Total Return	3.02%
Tr YTD	25.11
Tr15y	789.4%
Tr1m	12.7%
Tr1w	11.19%
Tr3m	21.68%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	SEK 452M
Operating Income Growth	-1.85
Operating Income Growth Q	-10.52
Operating Income Growth3 Y	10.55
Operating Income Growth5 Y	13.08
Operating margin	29.38

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	84,119,306%
Net Borrowing	-6,847,000
Shares Insiders	5.52%
Shares Institutions	35.79%
Shares Out	101,162,310
Shares Qo Q	0%
Shares Yo Y	0.09%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	SEK 303M
Average Volume	169,569.9x
Bv Per Share	12.99
CAPEX	SEK -3.5M
Ch10y	205.9
Ch15y	460
Ch1m	9.25
Ch1w	7.78
Ch1y	21.62
Ch20y	2,396.1
Ch3m	17.95
Ch3y	19.48
Ch5y	52.25
Ch6m	30.83
Change	1.74%
Change From Open	1.42
Close	126.6
Days Gap	0.32
Depreciation Amortization	16,944,000
Dollar Volume	45,645,303.2
Earnings Date	2026-05-07
EBIT	SEK 452M
EBITDA	SEK 468.9M
EPS	SEK 3.29
F Score	5
FCF	SEK 303M
FCF EV Yield	2.47x
FCF Per Share	SEK 3
Financing CF	-709,867,000
Fiscal Year End	December
Founded	1,990
Goodwill	146,496,000
Graham Number	31.00807
Graham Upside	-75.93
Income Tax	SEK 88.5M
Investing CF	-3,343,000
Is Primary Listing	1
Last Earnings Date	2026-05-07
Last Report Date	2025-12-31
Last Split Date	2022-05-18
Last Split Type	Forward
Lynch Fair Value	SEK 43.13
Lynch Upside	-66.52
Ma150	108.6
Ma150ch	18.6%
Ma20	120.7
Ma20ch	6.74%
Net CF	-422,674,000
Next Earnings Date	2026-07-17
Open	127
P FCF Ratio	43
P OCF Ratio	42.5
Payment Date	2026-05-15
Position In Range	76.19
Ppne	181,150,000
Price Date	2026-05-08
Price EBITDA	SEK 27.79
Ptbv Ratio	11.16
Relative Volume	2.09x
Revenue	1,538,168,000x
Tax By Revenue	5.75x
Tax Rate	21%
Tr20y	3,962.11%
Tr6m	34.96%
Volume	354,389
Z Score	25.58

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

STO/BIOG.B dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+3.1%

$4.00 annual per share

Payout ratio

+59.3%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+42.4%

0 consecutive years of growth

Total shareholder yield

+3.0%

Next ex-dividend date: 2026-05-08

Performance

STO/BIOG.B stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns STO/BIOG.B?

Insider, institutional, and short-interest positioning.

Institutional ownership

+35.8%

Share of float held by funds and institutions

Insider ownership

+5.5%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.1%

Negative means the company is buying back shares.

Technical

STO/BIOG.B momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

68.2

Neutral momentum band

Price vs 200-day MA

+20.7%

50/200-day relationship not available

Beta (5Y)

0.31

Less volatile than the market

Sharpe ratio

1.04

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About STO/BIOG.B

Hub-level FAQ points readers to the deeper analysis pages.

What is the current sto/BIOG.B stock rating?

sto/BIOG.B is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full sto/BIOG.B analysis?

The full report lives at /stocks/sto/BIOG.B/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for sto/BIOG.B?

The latest report frames sto/BIOG.B around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the sto/BIOG.B page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.